Approval · Notice of Compliance 18686 · 2016
TRELSTAR: Notice of Compliance 18686
Issued November 9, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18686
- Date
- November 9, 2016
- Company
- Allergan Pharma Co.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the design of the lyophilisation stopper
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRELSTAR | Not yet assigned | — |
Medicinal ingredients
- TRIPTORELIN PAMOATE 3.75 MG per VIAL
- TRIPTORELIN PAMOATE 11.25 MG per VIAL
- TRIPTORELIN PAMOATE 22.5 MG per VIAL